A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge
- 14 September 2010
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 28 (40), 6627-6636
- https://doi.org/10.1016/j.vaccine.2010.07.030
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Protective Immunity against Secondary Poxvirus Infection Is Dependent on Antibody but Not on CD4 or CD8 T-Cell FunctionJournal of Virology, 2006
- LC16m8, a Highly Attenuated Vaccinia Virus Vaccine Lacking Expression of the Membrane Protein B5R, Protects Monkeys from MonkeypoxJournal of Virology, 2006
- Physical and immunological characterization of a recombinant secreted form of the membrane protein encoded by the vaccinia virus L1R geneVirology, 2005
- Virulence differences between monkeypox virus isolates from West Africa and the Congo basinVirology, 2005
- Modified Vaccinia Virus Ankara Protects Macaques against Respiratory Challenge with Monkeypox VirusJournal of Virology, 2005
- Smallpox vaccine–induced antibodies are necessary and sufficient for protection against monkeypox virusNature Medicine, 2005
- Epitope-Mapping Studies Define Two Major Neutralization Sites on the Vaccinia Virus Extracellular Enveloped Virus Glycoprotein B5RJournal of Virology, 2005
- Smallpox vaccines: from first to second to third generationThe Lancet, 2005
- Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulinVirology, 2004
- The effector functions of immunoglobulins: implications for therapy.1995